The National Organization for Rare Disorders (NORD), an independent nonprofit organization that represents 30 million U.S. residents with rare diseases, recently received federal funds to help stop the Zika virus.
Chairmen and ranking members of the Senate Health Committee and House Energy and Commerce Committee recently stated that they are making progress in reaching a bipartisan deal for the 21st Century Cures legislation.
Chembio Diagnostics Inc., a leader in point-of-care (POC) diagnostic tests for infectious diseases, recently received a contract from the Centers for Disease Control and Prevention (CDC) for surveillance diagnostic assays for Zika, dengue and chikungunya.
Global Genes recently launched its fifth annual RARE Tribute to Champions of Hope and Patient Advocacy Summit, raising more than $1.4 million meant to fund rare disease awareness, education and grant programs.
The Leukemia and Lymphoma Society (LLS) and WealthEngine (WE), the top supplier of predictive analytics, marketing and audience development services, recently partnered to raise funds for blood cancer research.
The National Organization for Rare Disorders (NORD) recently joined over 300 organizations on Capitol Hill in the Rally for Medical Research Hill Day on Sept. 22, urging leaders to raise funds for the National Institutes of Health (NIH).
Sue Dubman, a health care and informatics researcher who has Parkinson’s disease, recently wrote an article in the 'Journal of Parkinson’s Disease' to explain that she wants to share her information to further scientific research.
Boehringer Ingelheim and ViraTherapeutics recently formed a long-term partnership to create a next-generation oncolytic virus therapy platform and evaluate a top candidate Vesicular Stomatitis Virus (VSV) glycoprotein (GP).
Amgen recently announced that its research has revealed new data for Imlygic (talimogene laherparepvec) to treat melanoma and metastatic colorectal cancer, stating that the information will be presented at the European Society for Medical Oncology 2016 Congress.
Millions of people receiving advanced tax credits under the Affordable Care Act either did not file the correct form with the IRS or did not file taxes at all, according to numbers crunched by an expert in health care policy.